Literature DB >> 8665804

Assessment of a combined anterior pituitary function test in beagle dogs: rapid sequential intravenous administration of four hypothalamic releasing hormones.

B P Meij1, J A Mol, H A Hazewinkel, M M Bevers, A Rijnberk.   

Abstract

A combined anterior pituitary (CAP) function test was assessed in eight healthy male beagle dogs. The CAP test consisted of sequential 30-second intravenous administrations of four hypothalamic releasing hormones in the following order and doses: 1 microgram of corticotropin-releasing hormone (CRH)/kg, 1 microgram of growth hormone-releasing hormone (GHRH)/kg, 10 micrograms of gonadotropin-releasing hormone (GnRH)/kg, and 10 micrograms of thyrotropin-releasing hormone (TRH)/kg. Plasma samples were assayed for adrenocorticotropin, cortisol, GH, luteinizing hormone (LH), and prolactin (PRL) at multiple times for 120 min after injection. Each releasing hormone was also administered separately in the same dose to the same eight dogs in order to investigate any interactions between the releasing hormones in the combined function test. Compared with separate administration, the combined administration of these four hypothalamic releasing hormones caused no apparent inhibition or synergism with respect to the responses to CRH, GHRH, and TRH. The combined administration of these four hypothalamic releasing hormones caused a 50% attenuation in LH response compared with the LH response to single GnRH administration. The side effects of the combined test were confined to restlessness and nausea in three dogs, which disappeared within minutes after the administration of the releasing hormones. It is concluded that with the rapid sequential administration of four hypothalamic releasing hormones (CRH, GHRH, GnRH, and TRH), the adenohypophyseal responses are similar to those occurring with the single administration of these secretagogues, with the exception of the LH response, which is lower in the CAP test than after single GnRH administration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8665804     DOI: 10.1016/0739-7240(95)00066-6

Source DB:  PubMed          Journal:  Domest Anim Endocrinol        ISSN: 0739-7240            Impact factor:   2.290


  4 in total

1.  A contracted DNA repeat in LHX3 intron 5 is associated with aberrant splicing and pituitary dwarfism in German shepherd dogs.

Authors:  Annemarie M W Y Voorbij; Frank G van Steenbeek; Manon Vos-Loohuis; Ellen E C P Martens; Jeanette M Hanson-Nilsson; Bernard A van Oost; Hans S Kooistra; Peter A Leegwater
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

2.  Pituitary dwarfism in Saarloos and Czechoslovakian wolfdogs is associated with a mutation in LHX3.

Authors:  A M W Y Voorbij; P A Leegwater; H S Kooistra
Journal:  J Vet Intern Med       Date:  2014-10-01       Impact factor: 3.333

3.  Utility of a corticotropin-releasing hormone test to differentiate pituitary-dependent hyperadrenocorticism from cortisol-producing adrenal tumors in dogs.

Authors:  Sachiyo Tanaka; Shuji Suzuki; Asaka Sato; Takahiro Teshima; Akihiro Mori; Toshinori Sako; Aki Tanaka; Yasushi Hara
Journal:  J Vet Intern Med       Date:  2021-12-03       Impact factor: 3.333

4.  Wellbeing, quality of life, presence of concurrent diseases, and survival times in untreated and treated German Shepherd dogs with dwarfism.

Authors:  Stefanie Kitzmann; Katrin Hartmann; Yury Zablotski; Anna Rieger; Ralf Mueller; Astrid Wehner
Journal:  PLoS One       Date:  2021-08-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.